Current portal location

Website content

WTO cases

Cases involving the EU

WT/DS114 - Patent protection of pharmaceutical product

Last update: 01/12/2003

  • Complaint by: EU
  • Complaint against: Canada
  • Third parties:
    Austria - Brazil - Colombia - Cuba - India - Israel - Japan - Poland - Switzerland - Thailand - United States
Summary of case:

Canada allows for start of commercial manufacture of patented medicines 6 months before the expiry of the patent and the manufacturing of the product for the purpose of securing the approval of generic medicines ("regulatory exception")

Relevant WTO provision:

TRIPS (27.1, 28, 30, 33)

Current situation:

EC prevailed on stockpiling exception. Implementation period (6 Months) determined by arbitration, ends on 7 Oct. 2000.

Consultation:

Date of request: 19/12/1997

Panel:

Date of request: 11/11/1998
Date of establishment: 01/02/1999
Date of circulation of report: 17/03/2003

Date of adoption - panel/AB report:

07/04/2000

Implementation deadline:

07/10/2000

Important legal notice

The information on this site is subject to a disclaimer and a copyright notice.